Nordea Investment Management’s Roivant Sciences ROIV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-406,859
Closed -$4.58M 879
2025
Q2
$4.58M Buy
406,859
+2,784
+0.7% +$30.2K ﹤0.01% 575
2025
Q1
$4.05M Buy
404,075
+121,241
+43% +$1.31M ﹤0.01% 577
2024
Q4
$3.31M Buy
282,834
+52,031
+23% +$615K ﹤0.01% 601
2024
Q3
$2.66M Sell
230,803
-9,241
-4% -$105K ﹤0.01% 640
2024
Q2
$2.51M Sell
240,044
-31,495
-12% -$345K ﹤0.01% 659
2024
Q1
$2.85M Buy
+271,539
New +$2.93M ﹤0.01% 652

Other funds holding ROIV

Nordea Investment Management's ROIV Position: Q3 2025 in Review

Nordea Investment Management sold out of Roivant Sciences (ROIV) in Q3 2025, closing a stake of 406,859 shares — an estimated $4.58M sold.

Nordea Investment Management first reported a position in ROIV in Q1 2024 and held it in 6 quarters. The position peaked at $4.58M in Q2 2025. 337 funds tracked by Wall St. Rank hold ROIV as of Q3 2025.

  • Nordea Investment Management reported no remaining Roivant Sciences position as of Q3 2025 after selling out during the quarter.
  • Nordea Investment Management sold 406,859 Roivant Sciences shares in Q3 2025, an estimated $4.58M.
  • Nordea Investment Management first reported a position in Roivant Sciences in Q1 2024 and held it in 6 quarters.
  • Nordea Investment Management's Roivant Sciences position peaked at $4.58M in Q2 2025.
  • 337 funds tracked by Wall St. Rank held Roivant Sciences as of Q3 2025.

Based on Nordea Investment Management's 13F filing for Q3 2025, filed 27 Oct 2025.